Detalhe da pesquisa
1.
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Nature
; 595(7868): 572-577, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34044428
2.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32998157
3.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Nature
; 585(7823): 107-112, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32728218
4.
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 566(7745): E13, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30733620
5.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 565(7738): 240-245, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30568303
6.
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 590(7844): E17, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33469214